Truvaga review: the gammaCore device, without a prescription

What Truvaga is — and why gammaCore matters here

Truvaga is a handheld device you hold against the side of the neck to deliver cervical vagus nerve stimulation. What sets it apart from most other neck-based devices in this category is its parentage: it's made by electroCore, the same company behind gammaCore — an FDA-cleared prescription device for migraine and cluster headache. That's a genuinely unusual position in this market — most taVNS/tcVNS brands have no regulatory-cleared sibling product at all, and users in migraine-focused communities have noticed and discussed exactly this point: you can buy Truvaga over the counter while gammaCore, essentially the same underlying approach, requires a prescription.

The gammaCore evidence: real relief, and a real cost problem

Because gammaCore requires a prescription and carries actual regulatory clearance for migraine, its user reports carry more weight than most devices we cover — this is not an unregulated wellness gadget making borrowed claims. One long-time chronic migraine patient, after 15-plus years of the condition and having already tried multiple triptans, Botox, an SPG block and monthly IV magnesium, described gammaCore as letting them walk around and function on days that would previously have been a write-off, paying out of pocket after insurance declined to cover the device.

But cost surfaces as the dominant complaint almost everywhere gammaCore is discussed. Reported figures cluster around $900 for the device plus roughly $400 per recharge, or about $600 every three months for ongoing sessions — a recurring expense that a meaningful share of long-term users say they can no longer sustain, insurance or not. That specific pain point is the reason Truvaga exists as a live option worth knowing about, rather than a curiosity: people who've confirmed cervical taVNS helps them via gammaCore, but can't keep affording the recharge cycle, are switching to the OTC sibling product specifically to keep the benefit without the recurring bill.

We couldn't find a published trial testing Truvaga itself, specifically, for migraine the way gammaCore has been studied — so treat any individual's experience switching between the two as a personal data point, not proof the two products perform identically. Shared engineering and a shared parent company is a reasonable basis for cautious optimism, not equivalence. For context on how trial quality varies across this whole category, see our evidence roundup.

Side effects: mostly mild, but with one serious report worth taking seriously

Most reported issues are genuinely mild: a tingling or buzzing sensation at the neck during sessions, and skin irritation with frequent use. One detailed account described real, meaningful benefit for two months — including successfully coming off a decade-long diazepam prescription used for sleep — before developing persistent eye strain and a severe headache at the back of the head, a pattern they suspected (without being certain) was linked to the vagus nerve's proximity to structures around the eye. That user's dilemma was genuine: the relaxation and sleep benefit was real enough that they wanted to keep using the device, but the head and eye pain made continued use difficult without adjusting the routine.

We also found one considerably more serious report that deserves to be presented carefully rather than either buried or sensationalized. A long-time user who had been using a Truvaga device for about a month, and had briefly paused after noticing mild headaches, resumed a session that went differently: a muscle near the trachea seized, followed by facial and neck paralysis-like sensations, jaw and facial pain, tingling, blurred vision in one eye, and numbness spreading through an arm and leg — severe enough to prompt an ER visit, where a stroke was ruled out but follow-up with a neurologist and optometrist was recommended. The person described the physical symptoms as bad, but the psychological aftermath — a persistent, one-sided fight-or-flight activation — as worse. This is, as far as we can tell, an isolated report rather than a pattern repeated by multiple independent users in the same terms, and cervical (neck) stimulation sits closer to major nerves and blood vessels than ear-based taVNS, which is precisely why starting at the lowest intensity and following placement instructions exactly matters more here than for an ear clip. We're including this not to suggest it's a common outcome — nothing else in this corpus suggests that — but because an honest safety section has to include the worst report we found, not just the median one.

Separately, and much less seriously: at least one Android user reported paying roughly $500 for a Truvaga device that would not pair with their phone at all, a problem that appeared to affect Android broadly rather than being a defective individual unit, and had to negotiate return shipping after initially being asked to cover it themselves. If you're on Android, it's worth confirming current app compatibility before buying rather than assuming it will work.

See our general safety guide for the broader precautions that apply across this device category.

Truvaga vs Nurosym (quick take)

Verdict

3 / 5. Truvaga's regulatory pedigree — sharing a parent company with an FDA-cleared, prescription migraine device — is a genuine point in its favor and something few competitors can claim. But it's priced and positioned as a general wellness product, not sold with gammaCore's specific medical claims, and we found no dedicated trial of Truvaga itself. If you already know cervical (neck) taVNS helps you, via gammaCore or otherwise, and the recurring cost is the barrier, Truvaga is a reasonable cost-saving option to investigate. If you're starting from scratch and mainly want general stress/HRV support, the ear-based route has a broader research base — see our Nurosym review.

Frequently asked questions

Is Truvaga the same as gammaCore?

They're made by the same parent company and use the same neck-based (cervical) vagus nerve stimulation approach. gammaCore is FDA-cleared and requires a prescription for migraine/cluster headache; Truvaga is sold over the counter as a general wellness device, without that specific medical clearance.

Why would I buy Truvaga instead of gammaCore?

Cost and access. gammaCore is expensive even with insurance and its recharges can run several hundred dollars every few months. Some users switch to Truvaga specifically because they can no longer afford gammaCore's recurring cost.

Does Truvaga work for migraine the way gammaCore does?

We could not find a trial testing Truvaga specifically for migraine the way gammaCore has been studied. Users switching from gammaCore to Truvaga for cost reasons are, in effect, testing this themselves — treat any given individual's result as anecdotal, not proof of equivalence.

What side effects does Truvaga cause?

Reports include mild skin irritation at the neck contact points and, in some threads, temporary discomfort during sessions. As with any neck-based (cervical) stimulation, start at the lowest setting.